Published in Circ Cardiovasc Qual Outcomes on September 01, 2009
Neutrophil-lymphocyte ratio as a new predictive and prognostic factor at the hearing loss of diabetic patients. Eur Arch Otorhinolaryngol (2014) 2.79
As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation (2013) 1.83
High Total Cholesterol in Peripheral Blood Correlates with Poorer Hearing Recovery in Idiopathic Sudden Sensorineural Hearing Loss. PLoS One (2015) 1.41
The predictive Value of Total Neutrophil Count and Neutrophil/Lymphocyte Ratio in Predicting In-hospital Mortality and Complications after STEMI. J Cardiovasc Thorac Res (2014) 1.15
Gene expression profiles associated with acute myocardial infarction and risk of cardiovascular death. Genome Med (2014) 1.04
White blood cell count, C-reactive protein, and incident heart failure in the Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol (2011) 0.93
Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients. BMC Endocr Disord (2015) 0.92
Usefulness of neutrophil-to-lymphocyte ratio in risk stratification of patients with advanced heart failure. Am J Cardiol (2014) 0.91
Disordered haematopoiesis and athero-thrombosis. Eur Heart J (2016) 0.85
The immunological axis in heart failure: importance of the leukocyte differential. Heart Fail Rev (2013) 0.84
Relationship between Plasma Pentraxin-3, Neutrophil-to-Lymphocyte Ratio, and Atherosclerosis in Renal Transplant Patients. Cardiorenal Med (2012) 0.84
The ratio of the neutrophil leucocytes to the lymphocytes predicts the outcome after cardiac resynchronization therapy. Europace (2015) 0.78
Hematological predictors and clinical outcomes in cardiac surgery. J Anesth (2016) 0.77
Neutrophil-to-lymphocyte ratio, insulin resistance, and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease. Indian J Nephrol (2013) 0.77
Mean platelet volume, red cell distribution width, platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in patients with ankylosing spondylitis and their relationships with high-frequency hearing thresholds. Eur Arch Otorhinolaryngol (2016) 0.77
Neutrophil-to-lymphocyte ratio as a possible indicator of epicardial adipose tissue in patients undergoing hemodialysis. Arch Med Sci (2016) 0.75
Association of TNFSF8 polymorphisms with peripheral neutrophil count. Mayo Clin Proc (2011) 0.75
Neutrophil Lymphocyte Ratio as a Predictor of Left Ventricular Apical Thrombus in Patients with Myocardial Infarction. Korean Circ J (2016) 0.75
The platelet-to-lymphocyte ratio as a predictor of all-cause mortality in patients with coronary artery disease undergoing elective percutaneous coronary intervention and stent implantation. J Saudi Heart Assoc (2015) 0.75
Platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in patients with rheumatoid arthritis. Open Med (Wars) (2015) 0.75
Intermediate-Risk Chronic Stable Angina: Neutrophil-Lymphocyte Ratio and Fibrinogen Levels Improved Predicting Angiographically-Detected Coronary Artery Disease. Iran Red Crescent Med J (2016) 0.75
Neutrophil to Lymphocyte Ratio in Patients with Nonarteritic Anterior Ischemic Optic Neuropathy. Korean J Ophthalmol (2017) 0.75
Neutrophil-to-lymphocyte ratio compared to N-terminal pro-brain natriuretic peptide as a prognostic marker of adverse events in elderly patients with chronic heart failure. J Geriatr Cardiol (2017) 0.75
Prognostic Value of Circulating Inflammatory Cells in Patients with Stable and Acute Coronary Artery Disease. Front Cardiovasc Med (2017) 0.75
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med (2008) 57.29
Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr (2005) 46.32
A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology (1983) 30.77
History of the Rochester Epidemiology Project. Mayo Clin Proc (1996) 21.72
Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J Clin Epidemiol (1996) 8.59
The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol (1993) 8.01
Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med (2009) 7.62
Widespread coronary inflammation in unstable angina. N Engl J Med (2002) 3.60
A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation (1981) 3.49
Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene? Arterioscler Thromb Vasc Biol (2005) 3.43
Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol (2005) 3.13
Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994. Ann Intern Med (2002) 2.87
Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation (2002) 2.67
Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol (2008) 2.26
The leukocyte count as a predictor of myocardial infarction. N Engl J Med (1974) 2.22
Incidence of heart failure after myocardial infarction: is it changing over time? Am J Epidemiol (2003) 2.03
Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation (2000) 2.01
Association of peripheral neutrophilia with adverse angiographic outcomes in ST-elevation myocardial infarction. Am J Cardiol (2004) 1.96
Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation (1998) 1.86
White blood cell count and cardiovascular disease. Insights from the Framingham Study. JAMA (1992) 1.75
Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta (2008) 1.66
High telomerase activity in neutrophils from unstable coronary plaques. J Am Coll Cardiol (2007) 1.61
Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. OPUS-TIMI 16 Investigators. Am J Cardiol (2001) 1.60
Leukocytes and coronary heart disease. Atherosclerosis (2004) 1.56
Lipoprotein-associated phospholipase A2 and prognosis after myocardial infarction in the community. Arterioscler Thromb Vasc Biol (2006) 1.43
Superiority of visual versus computerized echocardiographic estimation of radionuclide left ventricular ejection fraction. Am Heart J (1989) 1.39
The association between white blood cell count and acute myocardial infarction mortality in patients > or =65 years of age: findings from the cooperative cardiovascular project. J Am Coll Cardiol (2001) 1.37
Leukocyte counts and coronary heart disease in a Japanese cohort. Am J Epidemiol (1982) 1.32
Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction. Atherosclerosis (2006) 1.30
Neutrophil function in ischemic heart disease. Circulation (1989) 1.23
Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies. Am J Epidemiol (1997) 1.23
White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arterioscler Thromb Vasc Biol (1996) 1.20
Leukocyte counts and cerebrovascular disease. J Chronic Dis (1982) 1.18
Interleukin-6 induces demargination of intravascular neutrophils and shortens their transit in marrow. Am J Physiol Heart Circ Physiol (2000) 1.15
Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia. J Am Coll Cardiol (1996) 1.15
C-reactive protein and heart failure after myocardial infarction in the community. Am J Med (2007) 1.11
Pro-inflammatory cytokines in acute coronary syndromes: from bench to bedside. Cytokine Growth Factor Rev (2006) 1.08
Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. J Am Coll Cardiol (1990) 1.04
Incremental value of the leukocyte differential and the rapid creatine kinase-MB isoenzyme for the early diagnosis of myocardial infarction. Ann Intern Med (1995) 0.98
The association between white blood cell count and acute myocardial infarction in-hospital mortality: findings from the National Registry of Myocardial Infarction. Acad Emerg Med (2004) 0.97
Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapy. Eur Heart J (2008) 0.93
Duality of innate stress responses in cardiac injury, repair, and remodeling. J Mol Cell Cardiol (2004) 0.93
Leukocytosis and adverse hospital outcomes after acute myocardial infarction. Am J Cardiol (2003) 0.91
Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes. Am J Cardiol (2003) 0.90
Acute in vivo effects of IL-3 alone and in combination with IL-6 on the blood cells of the circulation and bone marrow. Am J Pathol (1989) 0.84
Comparison of four leukocyte differential methods with the National Committee for Clinical Laboratory Standards (NCCLS) reference method. Am J Clin Pathol (1987) 0.81
Neutrophils and altered myocardial function. Am Heart J (2000) 0.79
Leukocytes as a coronary risk factor in a dyslipidemic male population. Am Heart J (1992) 0.77
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89
Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2010) 9.18
Trends in heart failure incidence and survival in a community-based population. JAMA (2004) 8.90
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13
Systolic and diastolic heart failure in the community. JAMA (2006) 5.99
Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum (2005) 5.31
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation (2002) 4.99
Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol (2009) 4.16
Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation (2007) 3.78
Myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, before and after smoke-free workplace laws. Arch Intern Med (2012) 3.77
Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med (2002) 3.71
Hospitalizations after heart failure diagnosis a community perspective. J Am Coll Cardiol (2009) 3.42
Why patients visit their doctors: assessing the most prevalent conditions in a defined American population. Mayo Clin Proc (2013) 3.40
Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn, 1970-1994. Arch Intern Med (2003) 3.13
Left atrial volume: a powerful predictor of survival after acute myocardial infarction. Circulation (2003) 3.08
Trends in incidence, severity, and outcome of hospitalized myocardial infarction. Circulation (2010) 3.07
Pulmonary pressures and death in heart failure: a community study. J Am Coll Cardiol (2012) 2.98
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol (2011) 2.89
Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994. Ann Intern Med (2002) 2.87
Redefinition of myocardial infarction: prospective evaluation in the community. Circulation (2006) 2.76
The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum (2005) 2.74
Atrial fibrillation and death after myocardial infarction: a community study. Circulation (2011) 2.63
Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis. Circulation (2011) 2.63
Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation (2005) 2.61
Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of "normal weight central obesity". J Am Coll Cardiol (2013) 2.61
Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction. Circ Heart Fail (2012) 2.53
Cardiac rehabilitation after myocardial infarction in the community. J Am Coll Cardiol (2004) 2.52
Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol (2011) 2.50
Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol. Circulation (2007) 2.47
Death in heart failure: a community perspective. Circ Heart Fail (2008) 2.46
Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. J Am Coll Cardiol (2009) 2.34
Coronary heart disease death and sudden cardiac death: a 20-year population-based study. Am J Epidemiol (2003) 2.34
Predictors of neurologic outcome in hypothermia after cardiac arrest. Ann Neurol (2010) 2.33
Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality. Ann Intern Med (2015) 2.31
Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study. Circ Heart Fail (2012) 2.26
Noninvasive estimation of left ventricular filling pressure by E/e' is a powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol (2004) 2.25
Sudden death after myocardial infarction. JAMA (2008) 2.24
Secular trends in deaths from cardiovascular diseases: a 25-year community study. Circulation (2006) 2.24
Lifetime costs of medical care after heart failure diagnosis. Circ Cardiovasc Qual Outcomes (2010) 2.19
Electronic medical records for clinical research: application to the identification of heart failure. Am J Manag Care (2007) 2.18
Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med (2006) 2.09
Coronary disease surveillance in Olmsted County objectives and methodology. J Clin Epidemiol (2002) 2.06
Incidence of heart failure after myocardial infarction: is it changing over time? Am J Epidemiol (2003) 2.03
The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol (2002) 2.03
Scores for post-myocardial infarction risk stratification in the community. Circulation (2002) 1.98
A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc (2009) 1.98
The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum (2008) 1.94
Increased cardiovascular mortality after early bilateral oophorectomy. Menopause (2009) 1.89
Temporal trends in the incidence of coronary disease. Am J Med (2004) 1.86
The influence of rheumatoid arthritis disease characteristics on heart failure. J Rheumatol (2011) 1.82
Clinical determinants of radiation dose in percutaneous coronary interventional procedures: influence of patient size, procedure complexity, and performing physician. JACC Cardiovasc Interv (2011) 1.80
Mortality differences between men and women after percutaneous coronary interventions. A 25-year, single-center experience. J Am Coll Cardiol (2008) 1.78
Long-term outcomes of fractional flow reserve-guided vs. angiography-guided percutaneous coronary intervention in contemporary practice. Eur Heart J (2013) 1.76
Heart failure after myocardial infarction: a review. Am J Med (2002) 1.76
Seasonality and daily weather conditions in relation to myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, 1979 to 2002. J Am Coll Cardiol (2006) 1.73
Cardiovascular health: the importance of measuring patient-reported health status: a scientific statement from the American Heart Association. Circulation (2013) 1.73
Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease. Circulation (2004) 1.73
Outcome of patients with a final diagnosis of chest pain of undetermined origin admitted under the suspicion of acute coronary syndrome: a report from the Rochester Epidemiology Project. Ann Emerg Med (2004) 1.71
Factors associated with 30-day readmission rates after percutaneous coronary intervention. Arch Intern Med (2011) 1.70
Patent foramen ovale in cryptogenic stroke: current understanding and management options. Arch Intern Med (2004) 1.70
Recent trends in the prevalence of coronary disease: a population-based autopsy study of nonnatural deaths. Arch Intern Med (2008) 1.69
Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum (2007) 1.67
Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. J Am Coll Cardiol (2002) 1.64
Frequency and correlates of coronary stent thrombosis in the modern era: analysis of a single center registry. J Am Coll Cardiol (2002) 1.62
Prognostic value of biomarkers in heart failure: application of novel methods in the community. Circ Heart Fail (2009) 1.62
Successful percutaneous repair of perivalvular prosthetic regurgitation. Catheter Cardiovasc Interv (2007) 1.60
Diastolic stiffness as assessed by diastolic wall strain is associated with adverse remodelling and poor outcomes in heart failure with preserved ejection fraction. Eur Heart J (2012) 1.58